BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20046837)

  • 1. P19 H-ras induces G1/S phase delay maintaining cells in a reversible quiescence state.
    Camats M; Kokolo M; Heesom KJ; Ladomery M; Bach-Elias M
    PLoS One; 2009 Dec; 4(12):e8513. PubMed ID: 20046837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.
    García-Cruz R; Camats M; Calin GA; Liu CG; Volinia S; Taccioli C; Croce CM; Bach-Elias M
    BMC Med Genet; 2015 Jul; 16():46. PubMed ID: 26138095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein that trafficks to cytoplasm and nucleus.
    Guil S; de La Iglesia N; Fernández-Larrea J; Cifuentes D; Ferrer JC; Guinovart JJ; Bach-Elias M
    Cancer Res; 2003 Sep; 63(17):5178-87. PubMed ID: 14500341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation.
    Guil S; Gattoni R; Carrascal M; Abián J; Stévenin J; Bach-Elias M
    Mol Cell Biol; 2003 Apr; 23(8):2927-41. PubMed ID: 12665590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p19(ras) amplifies p73beta-induced apoptosis through mitochondrial pathway.
    Kim JW; Kim WH; Jeong MH; Jang SM; Song KH; Park SI; Song PI; Kang KH; Choi KH
    Biochem Biophys Res Commun; 2008 Aug; 373(1):146-50. PubMed ID: 18555006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.
    Zhang W; Veisaga ML; Barbieri MA
    Exp Cell Res; 2020 Nov; 396(2):112318. PubMed ID: 33069695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p73 cooperates with Ras in the activation of MAP kinase signaling cascade.
    Fernandez-Garcia B; Vaqué JP; Herreros-Villanueva M; Marques-Garcia F; Castrillo F; Fernandez-Medarde A; León J; Marín MC
    Cell Death Differ; 2007 Feb; 14(2):254-65. PubMed ID: 16645632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alternative H-ras protein p19 displays properties of a negative regulator of p21Ras.
    Huang MY; Cohen JB
    Oncol Res; 1997; 9(11-12):611-21. PubMed ID: 9563009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.
    Lin X; Nelson P; Gelman IH
    Mol Cell Biol; 2000 Oct; 20(19):7259-72. PubMed ID: 10982843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras signals principally via Erk in G1 but cooperates with PI3K/Akt for Cyclin D induction and S-phase entry.
    Vasjari L; Bresan S; Biskup C; Pai G; Rubio I
    Cell Cycle; 2019 Jan; 18(2):204-225. PubMed ID: 30560710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.
    Komatsu N; Fujita Y; Matsuda M; Aoki K
    Oncogene; 2015 Nov; 34(45):5607-16. PubMed ID: 25703330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
    Akagi T; Murata K; Shishido T; Hanafusa H
    Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts.
    Takuwa N; Takuwa Y
    Mol Cell Biol; 1997 Sep; 17(9):5348-58. PubMed ID: 9271412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oh8dG induces G1 arrest in a human acute leukemia cell line by upregulating P21 and blocking the RAS to ERK signaling pathway.
    Hyun JW; Yoon SH; Yu Y; Han CS; Park JS; Kim HS; Lee SJ; Lee YS; You HJ; Chung MH
    Int J Cancer; 2006 Jan; 118(2):302-9. PubMed ID: 16052517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1.
    Han L; Colicelli J
    Mol Cell Biol; 1995 Mar; 15(3):1318-23. PubMed ID: 7862125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal cell kinase, a MAP kinase-related kinase, regulates proliferation and G1 cell cycle progression of intestinal epithelial cells.
    Fu Z; Kim J; Vidrich A; Sturgill TW; Cohn SM
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G632-40. PubMed ID: 19696144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma.
    Lin YW; Beharry ZM; Hill EG; Song JH; Wang W; Xia Z; Zhang Z; Aplan PD; Aster JC; Smith CD; Kraft AS
    Blood; 2010 Jan; 115(4):824-33. PubMed ID: 19965690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.